BME, a US-based manufacturer of Nitinol metal implants for musculoskeletal fixation, has announced the issuance of a new US patent ‘method and apparatus for an orthopedic fixation system’ as part of its Speed and Speed Shift (fully-disposable continuous active compression system) brands.
The US patent is related to the combination of a compressive implant pre-loaded on an insertion device and packaged sterile, promoting efficiencies within the hospital surgical suite.
BME president and CEO Keith M Peeples noted this patent acknowledges and rewards the ingenuity fostered within a small company environment.
"The patent helps establish the foundation needed to build the most comprehensive Continuous Active Compression System, which will meet the expanding needs of surgeons and their patients. Innovation is the driving force required to deliver clinically relevant surgical solutions," Peeples added.
The company said that it will continue to focus on developing a product pipeline that defines its commitment to bringing innovative technology to the extremity market not only in implant design, but in application and delivery.
